• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Public Health . Omicron variant and pulmonary involvements: a chest imaging analysis in asymptomatic and mild COVID-19

tetano

Editor, Senior Moderator
Front Public Health


. 2024 Jul 4:12:1325474.
doi: 10.3389/fpubh.2024.1325474. eCollection 2024. Omicron variant and pulmonary involvements: a chest imaging analysis in asymptomatic and mild COVID-19

Peiben Liu[SUP] #[/SUP][SUP] 1 2 [/SUP], Kejun Cao[SUP] #[/SUP][SUP] 2 [/SUP], Guanqun Dai[SUP] #[/SUP][SUP] 3 [/SUP], Tingzhen Chen[SUP] 2 [/SUP], Yifan Zhao[SUP] 2 [/SUP], Hai Xu[SUP] 4 [/SUP], Xiaoquan Xu[SUP] 4 [/SUP], Quan Cao[SUP] 2 [/SUP], Yiyang Zhan[SUP] 3 [/SUP], Xiangrong Zuo[SUP] 2 [/SUP]



Affiliations
Abstract

Objectives: To identify clinical characteristics and risk factors for pulmonary involvements in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2 Omicron variant by chest imaging analysis.
Methods: Detailed data and chest computed tomography (CT) imaging features were retrospectively analyzed from asymptomatic and mildly symptomatic patients infected with Omicron between 24 April and 10 May 2022. We scored chest CT imaging features and categorized the patients into obvious pulmonary involvements (OPI) (score > 2) and not obvious pulmonary involvements (NOPI) (score ≤ 2) groups based on the median score. The risk factors for OPI were identified with analysis results visualized by nomogram.
Results: In total, 339 patients were included (145 were male and 194 were female), and the most frequent clinical symptoms were cough (75.5%); chest CT imaging features were mostly linear opacities (42.8%). Pulmonary involvements were more likely to be found in the left lower lung lobe, with a significant difference in the lung total severity score of the individual lung lobes (p < 0.001). Logistic regression analysis revealed age stratification [odds ratio (OR) = 1.92, 95% confidence interval (CI) (1.548-2.383); p < 0.001], prolonged nucleic acid negative conversion time (NCT) (NCT > 8d) [OR = 1.842, 95% CI (1.104-3.073); p = 0.019], and pulmonary diseases [OR = 4.698, 95% CI (1.159-19.048); p = 0.03] as independent OPI risk factors.
Conclusion: Asymptomatic and mildly symptomatic patients infected with Omicron had pulmonary involvements which were not uncommon. Potential risk factors for age stratification, prolonged NCT, and pulmonary diseases can help clinicians to identify OPI in asymptomatic and mildly symptomatic patients infected with Omicron.

Keywords: SARS-CoV-2 omicron variant; chest imaging; clinical features; lung total severity score; pulmonary involvements.

 
Back
Top Bottom